FDA Inspection
Aultman HospitalAultman Hospital – FDA Inspection, Jan 24, 2020
Record Details
This FDA Inspection record concerns Aultman Hospital, with an inspection on January 24, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Aultman Hospital
- Inspection Date
- January 24, 2020
- Product Type
- Biologics
View Company Profile
ID · a555f794-d7d3-4501-8662-b674bc7aaf95
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1115744
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Aultman Hospital
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 7, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 4, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 17, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 21, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 8, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Aultman Hospital
- FDA Inspection 1226084 - 2023-12-07
- FDA Inspection 1078054 - 2019-02-04
- FDA Inspection 997341 - 2017-01-17
- FDA Inspection 908867 - 2015-01-21
- FDA Inspection 817778 - 2013-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.